MX2016011729A - Composicion y metodo de liberacion prolongada. - Google Patents

Composicion y metodo de liberacion prolongada.

Info

Publication number
MX2016011729A
MX2016011729A MX2016011729A MX2016011729A MX2016011729A MX 2016011729 A MX2016011729 A MX 2016011729A MX 2016011729 A MX2016011729 A MX 2016011729A MX 2016011729 A MX2016011729 A MX 2016011729A MX 2016011729 A MX2016011729 A MX 2016011729A
Authority
MX
Mexico
Prior art keywords
controlled release
dosage form
release composition
coalescing agent
coating
Prior art date
Application number
MX2016011729A
Other languages
English (en)
Inventor
S Yang Hui
Ma Hua
Stokes Kevin
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of MX2016011729A publication Critical patent/MX2016011729A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En un aspecto la presente invención se dirige a un método para realizar una forma de dosificación sólida de liberación controlada que tiene una capa de recubrimiento de etilcelulosa, esa capa comprende un agente de coalescencia que es un éster orgánico que tiene un valor HLB de 3 a 8. El uso de ese agente de coalescencia permite la formación de un recubrimiento de liberación controlada efectivo sin la necesidad de una etapa posterior de curado después del proceso de recubrimiento. En otros aspectos, esta invención se refiere a una dispersión acuosa útil en tal método; así como la forma de dosificación recubierta producida.
MX2016011729A 2014-03-11 2015-03-04 Composicion y metodo de liberacion prolongada. MX2016011729A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461951065P 2014-03-11 2014-03-11
US201462073365P 2014-10-31 2014-10-31
PCT/US2015/018743 WO2015138200A1 (en) 2014-03-11 2015-03-04 Controlled release composition and method

Publications (1)

Publication Number Publication Date
MX2016011729A true MX2016011729A (es) 2016-10-28

Family

ID=54067754

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016011729A MX2016011729A (es) 2014-03-11 2015-03-04 Composicion y metodo de liberacion prolongada.

Country Status (8)

Country Link
US (3) US20150258033A1 (es)
EP (1) EP3116483B1 (es)
JP (1) JP6616780B2 (es)
CN (1) CN106102723B (es)
BR (1) BR112016020738B1 (es)
CA (1) CA2940684C (es)
MX (1) MX2016011729A (es)
WO (1) WO2015138200A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
KR102113261B1 (ko) 2018-03-28 2020-05-20 주식회사 엘지화학 용출 제어형 비료

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4629753A (en) 1981-11-18 1986-12-16 The Lubrizol Corporation Water dispersed rust inhibitive coating compositions
NZ221411A (en) * 1986-08-11 1989-10-27 Innovata Biomed Ltd Pharmaceutical compositions containing microcapsules and a surfactant
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5273760A (en) 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5853740A (en) * 1996-08-07 1998-12-29 Abbott Laboratories Delivery system for pharmaceutical agents encapsulated with oils
US5695551A (en) * 1996-12-09 1997-12-09 Dow Corning Corporation Water repellent composition
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EP1896002A4 (en) * 2005-06-27 2009-11-25 Biovail Lab Int Srl BUPROPIONAL SALT FORMULATIONS WITH MODIFIED RELEASE
AU2006284053B2 (en) * 2005-08-22 2010-04-22 Novartis Ag Pharmaceutical compositions comprising a pH-dependent drug, a pH modifier and a retarding agent
US7829148B2 (en) 2006-02-07 2010-11-09 Fmc Corporation Coating process to produce controlled release coatings
US8088414B2 (en) * 2006-02-07 2012-01-03 Fmc Corporation Latex or pseudolatex compositions, coatings and coating processes
WO2010060008A1 (en) 2008-11-21 2010-05-27 Elementis Specialties, Inc. Voc-free coalescing agent
CN101919803A (zh) * 2010-07-16 2010-12-22 钟术光 一种控释制剂

Also Published As

Publication number Publication date
CA2940684C (en) 2023-05-02
WO2015138200A1 (en) 2015-09-17
CN106102723B (zh) 2021-06-25
JP6616780B2 (ja) 2019-12-04
CN106102723A (zh) 2016-11-09
CA2940684A1 (en) 2015-09-17
BR112016020738B1 (pt) 2023-04-11
EP3116483A4 (en) 2017-11-08
EP3116483B1 (en) 2021-04-21
US20230072225A1 (en) 2023-03-09
US20180360763A1 (en) 2018-12-20
EP3116483A1 (en) 2017-01-18
BR112016020738A2 (pt) 2017-08-15
US20150258033A1 (en) 2015-09-17
JP2017507164A (ja) 2017-03-16

Similar Documents

Publication Publication Date Title
MY174610A (en) Process for preparing a surface-modified material
MX2017004896A (es) Uso de hexadeca-8, 15-dienal como producto quimico aromatico.
SA517381769B1 (ar) توليد حمض بيروكسي فورميك من خلال فورمات كحول بولي هيدريك
BR112017007864A2 (pt) método e sistema de tratamento de uma formação subterrânea, sistema para realizar um método, composição de peso aumentado, e, método de preparo de uma composição de peso aumentado.
MX2018003280A (es) Proceso de compuesto antifungico.
PH12016500630A1 (en) Treated fillers, compositions containing same, and articles prepared therefrom
PH12016501985A1 (en) Rapid set aqueous coatings
MX2017002865A (es) Formulacion de pintura tipo piedra y metodos para producir la misma.
CL2018000451A1 (es) Composiciones de micropartículas que comprenden saflufenacil
MX2017010882A (es) Un producto de concreto fotocatalitico y un metodo para generar un producto de concreto fotocatalitico.
PL3121253T3 (pl) Kompozycja stałej powłoki smarującej, gwintowanych połączeń rur lub rurek, w tym stałych powłok smarowych wykonanych z kompozycji oraz sposób wytwarzania połączenia gwintowanego
EP3345977A4 (en) COATING MATERIAL FOR PREVENTING METAL CORROSION, AND PROCESS FOR PRODUCING COATING FILM FOR PREVENTING METAL CORROSION
EP3438194A4 (en) PROCESS FOR PRODUCING POLYMER COMPOSITION CONTAINING CARBOXYL GROUPS
MX2016007755A (es) Revestimiento de poliester modificado con silicona.
GB2556735A (en) Weighted composition for treatment of a subterranean formation
EP3816246A4 (en) AQUEOUS COATING COMPOSITION AND METHOD FOR PREPARING AN AQUEOUS COATING COMPOSITION
EP3455312A4 (en) AQUEOUS COATING COMPOSITION AND METHOD FOR PRODUCING THE SAME
EP3498740A4 (en) COATING COMPOSITION, PROCESS FOR PREPARING AN ORGANIC ELECTROLUMINESCENT DEVICE AND ORIGINAL ELECTROLUMINESCENT DEVICE MANUFACTURED THEREWITH
MX2017006406A (es) Proceso para producir ajoeno.
GB2547812A (en) Proppant composition and method
MX2016011729A (es) Composicion y metodo de liberacion prolongada.
PH12016501525A1 (en) Water-based epoxy formulations for applied fireproofing
EP3498794A4 (en) COATING COMPOSITION DISPERSION, AQUEOUS COMPOSITE DISPERSION AND METHOD FOR PRODUCING AN AQUEOUS COMPOSITE DISPERSION
PH12016501626A1 (en) Aqueous resin composition for forming thick film, manufacturing method therefor, surface treatment method, and concrete structure
PL411644A1 (pl) Kompozycja powłokowa w postaci termoutwardzalnego proszku